لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Msaouel P; University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: PMsaouel@mdanderson.org., Sweis RF; University of Chicago Medicine, Chicago, IL, USA., Bupathi M; Rocky Mountain Cancer Centers - Littleton, Littleton, CO, USA., Heath E; Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA., Goodman OB Jr; Comprehensive Cancer Centers of Nevada - Southwest, Las Vegas, NV, USA., Hoimes CJ; Duke University Hospital, Durham, NC, USA., Milowsky MI; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Davis N; Vanderbilt - Ingram Cancer Center, Nashville, TN, USA., Kalebasty AR; University of California Irvine, Irvine, CA, USA., Picus J; Washington University School of Medicine, Siteman Cancer Center, Saint Louis, MO, USA., Shaffer D; New York Oncology Hematology - Albany Medical Center, Albany, NY, USA., Mao S; Allegheny General Hospital, Pittsburgh, PA, USA., Adra N; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA., Yorio J; Texas Oncology - Austin Central, Austin, TX, USA., Gandhi S; Florida Cancer Specialists and Research Institute - North Region (SCRI), Tampa Bay, FL, USA., Grivas P; Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA., Siefker-Radtke A; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yang R; Mirati Therapeutics, Inc., San Diego, CA, USA., Latven L; Mirati Therapeutics, Inc., San Diego, CA, USA., Olson P; Mirati Therapeutics, Inc., San Diego, CA, USA., Chin CD; Mirati Therapeutics, Inc., San Diego, CA, USA., Der-Torossian H; Mirati Therapeutics, Inc., San Diego, CA, USA., Mortazavi A; Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, and the Comprehensive Cancer Center, Columbus, OH, USA., Iyer G; Memorial Sloan Kettering Cancer Center, New York, NY, USA.

المصدر: European urology oncology [Eur Urol Oncol] 2024 Aug; Vol. 7 (4), pp. 933-943. Date of Electronic Publication: 2023 Dec 16.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Nivolumab*/therapeutic use , Carcinoma, Transitional Cell*/drug therapy , Carcinoma, Transitional Cell*/secondary , Carcinoma, Transitional Cell*/pathology , Carcinoma, Transitional Cell*/mortality , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Aged ; Male ; Female ; Middle Aged ; Aged, 80 and over ; Adult ; Neoplasm Metastasis ; Urologic Neoplasms/drug therapy ; Urologic Neoplasms/pathology ; Urologic Neoplasms/mortality ; Urinary Bladder Neoplasms/drug therapy ; Urinary Bladder Neoplasms/pathology

المؤلفون: Karam JA; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. jakaram@mdanderson.org.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. jakaram@mdanderson.org., Msaouel P; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. PMsaouel@mdanderson.org.; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. PMsaouel@mdanderson.org.; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA. PMsaouel@mdanderson.org., Haymaker CL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Matin SF; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Campbell MT; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zurita AJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shah AY; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Marmonti E; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Duose DY; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Parra ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Soto LMS; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Laberiano-Fernandez C; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Lozano M; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Abraham A; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Hallin M; Mirati Therapeutics, Inc., San Diego, CA, 92121, USA., Chin CD; Mirati Therapeutics, Inc., San Diego, CA, 92121, USA., Olson P, Der-Torossian H; Mirati Therapeutics, Inc., San Diego, CA, 92121, USA., Yan X; Mirati Therapeutics, Inc., San Diego, CA, 92121, USA., Tannir NM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wood CG; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

المصدر: Nature communications [Nat Commun] 2023 May 10; Vol. 14 (1), pp. 2684. Date of Electronic Publication: 2023 May 10.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Renal Cell*/drug therapy , Carcinoma, Renal Cell*/surgery , Carcinoma, Renal Cell*/etiology , Kidney Neoplasms*/drug therapy , Kidney Neoplasms*/surgery , Kidney Neoplasms*/etiology, Humans ; Nivolumab/adverse effects ; Neoadjuvant Therapy ; Nephrectomy ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Tumor Microenvironment

المؤلفون: Chin CD; Advanced Materials Laboratory, Sandia National Laboratories, 1001 University Blvd. SE, Suite 100, Albuquerque, NM 87106, USA. ljtread@sandia.gov., Ringgold MA; Advanced Materials Laboratory, Sandia National Laboratories, 1001 University Blvd. SE, Suite 100, Albuquerque, NM 87106, USA. ljtread@sandia.gov., Redline EM; Sandia National Laboratories, P.O. Box 5800, Albuquerque, NM 87185, USA., Bregman AG; Advanced Materials Laboratory, Sandia National Laboratories, 1001 University Blvd. SE, Suite 100, Albuquerque, NM 87106, USA. ljtread@sandia.gov., Hattar K; Sandia National Laboratories, P.O. Box 5800, Albuquerque, NM 87185, USA., Peretti AS; Sandia National Laboratories, P.O. Box 5800, Albuquerque, NM 87185, USA., Treadwell LJ; Advanced Materials Laboratory, Sandia National Laboratories, 1001 University Blvd. SE, Suite 100, Albuquerque, NM 87106, USA. ljtread@sandia.gov.

المصدر: Physical chemistry chemical physics : PCCP [Phys Chem Chem Phys] 2022 Mar 16; Vol. 24 (11), pp. 6552-6569. Date of Electronic Publication: 2022 Mar 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 100888160 Publication Model: Electronic Cited Medium: Internet ISSN: 1463-9084 (Electronic) Linking ISSN: 14639076 NLM ISO Abbreviation: Phys Chem Chem Phys Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Chin CD; Department of Chemistry and Advanced Materials Research Institute, University of New Orleans, New Orleans, LA 70148, USA.; Advanced Materials Laboratory, Sandia National Laboratories, 1001 University Blvd. SE, Suite 100, Albuquerque, NM 87106, USA., Treadwell LJ; Advanced Materials Laboratory, Sandia National Laboratories, 1001 University Blvd. SE, Suite 100, Albuquerque, NM 87106, USA., Wiley JB; Department of Chemistry and Advanced Materials Research Institute, University of New Orleans, New Orleans, LA 70148, USA.

المصدر: Molecules (Basel, Switzerland) [Molecules] 2021 Jun 15; Vol. 26 (12). Date of Electronic Publication: 2021 Jun 15.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049 (Electronic) Linking ISSN: 14203049 NLM ISO Abbreviation: Molecules Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Yu W; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles (UCLA), Los Angeles, California, USA., Rao E; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles (UCLA), Los Angeles, California, USA., Chin CD; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles (UCLA), Los Angeles, California, USA., Aguilar-Jakthong JS; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles (UCLA), Los Angeles, California, USA., Li Y; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles (UCLA), Los Angeles, California, USA., Chow C; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles (UCLA), Los Angeles, California, USA., Wang SYG; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles (UCLA), Los Angeles, California, USA., Rao J; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles (UCLA), Los Angeles, California, USA.

المصدر: Acta cytologica [Acta Cytol] 2021; Vol. 65 (4), pp. 348-353. Date of Electronic Publication: 2021 Jun 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Karger Country of Publication: Switzerland NLM ID: 0370307 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-2650 (Electronic) Linking ISSN: 00015547 NLM ISO Abbreviation: Acta Cytol Subsets: MEDLINE

مواضيع طبية MeSH: Cytodiagnosis* , Deep Learning* , Diagnosis, Computer-Assisted* , Fluorescent Antibody Technique* , Image Processing, Computer-Assisted* , Microscopy, Fluorescence*, Adenocarcinoma/*chemistry , Biomarkers, Tumor/*analysis , Pleural Effusion, Malignant/*chemistry, Adenocarcinoma/secondary ; Diagnosis, Differential ; Feasibility Studies ; Humans ; Pleural Effusion, Malignant/pathology ; Predictive Value of Tests ; Reproducibility of Results ; Retrospective Studies